title: [Dynamics of pro-and anti-inflammatory cytokines at patients with combination of chronic opisthorchiasis with Helicobacter pylori-associated gastritis].
abstract: The aim of our study was to estimate the cytokins changes (TNF alpha, IL-1 beta, IL-8, IL-4) in patients with combination of chronic opisthorhosis and Helicobacter pylori associated gastritis and to estimate degelmintizational therapy with biltricid on cytokine levels. The 55 patients were investigated and divided on two groups: isolated opisthorhosis -- 20 patients and opisthorhosis in combination with Helicobacter pylori associated gastritis -- 35 patients. In both groups of patients was estimated the increase of TNF alpha, IL-1 beta, IL-8, IL-4 levels. The treatment with biltricid allow to decrease the TNF alpha, IL-1beta, IL-8 levels and to increase IL-4 level, especially in patients with combination of chronic opisthorhosis and Helicobacter pylori associated gastritis.
authors: V A
authors: VA
authors: Akhmedov
authors: M A
authors: MA
authors: Kritevich
authors: V A
authors: VA
authors: Ostapenko
authors: T F
authors: TF
authors: Sokolova
mesh_terms: D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D016207:Cytokines / Q000097:blood*; D005260:Female; D005756:Gastritis / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D009889:Opisthorchiasis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011223:Praziquantel / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D016207:Cytokines; D011223:Praziquantel